Details of the Drug

General Information of Drug (ID: DM9M5WV)

Drug Name
MRG-201
Indication
Disease Entry ICD 11 Status REF
Keloid EE60 Phase 2 [1]
Scleroderma 4A42 Phase 1 [2]
Cross-matching ID
TTD ID
D08WZQ
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Collagen (CO) TTK982E NOUNIPROTAC Modulator [2]
microRNA hsa-miR-155 (MIR155) TT1GNRQ NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03601052) Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)